Optic neuropathy in methylmalonic acidemia: The role of neuroprotection

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages

  Pinar Sueiro, Sergio ^a,b   Martínez Fernández, Ricardo ^a   Lage Medina, Sergio ^a   Aldamiz Echevarria, Luis ^a   Vecino, Elena ^b  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT; UBIDECARENONE; UBIQUINONE;

ADOLESCENT; ARTICLE; CASE REPORT; CELL CULTURE; CONVALESCENCE; DIET SUPPLEMENTATION; DIET THERAPY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DRUG COMBINATION; FEMALE; GENETICS; HUMAN; METHYLMALONIC ACIDEMIA; NUCLEOTIDE SEQUENCE; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PROTEIN RESTRICTION; TIME; TREATMENT OUTCOME; VISUAL ACUITY; AMINO ACID METABOLISM, INBORN ERRORS; ANALOGS AND DERIVATIVES; COMPLICATION; OPTIC NERVE DISEASES;

ADOLESCENT; AMINO ACID METABOLISM, INBORN ERRORS; ANTIOXIDANTS; CELLS, CULTURED; DIET, PROTEIN-RESTRICTED; DIETARY SUPPLEMENTS; DNA MUTATIONAL ANALYSIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; NEUROPROTECTIVE AGENTS; OPTIC NERVE DISEASES; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME; UBIQUINONE; VISUAL ACUITY; VITAMIN E;

EID: 84897928136     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9084-8     Document Type: Article

References (13)

1. Deodato F, Boenzi S, Santorelli FM,Dionisi-Vici C (2006) Methylmalonic and propionic aciduria. Am J Med Genet Part C Semin Med Genet 142:104-112
2. Yannicelli S (2006) Nutrition therapy of organic acidaemias with amino acid-based formulas: Emphasis on methylmalonic and propionic acidaemia. J Inherit Metab Dis 29:281-287
3. Costeff H, Elpeleg O, Apter N, Divry P, Gadoth N (1993) 3-Methylglutaconic aciduria in "optic athropy plus". Ann Neurol 33:103-104
4. Patton N, Beatty S, Lloyd IC, Wraith JE (2000) Optic athropy in association with cobalamin C (Cbl C) disease. Ophthalmic Genet 21:151-154
5. Williams ZR, Hurley PE, Altiparmak UE, Feldon SE, Arnold GL, Eggenberger E, Mejico LJ (2009) Late onset optic neuropathy in methylmalonic and propionic acidemia. Am J Ophthalmol 147:929-933
6. Kanaumi T, Takashima S, Hirose S, Kodama T, Iwasaki H (2006) Neuropathology of methylmalonic acidemia in a child. Pediatr Neurol 34:156-159
7. Kowaltowski AJ, Maciel EN, Fornazari M, Castilho RF (2006) Diazoxide protects against methylmalonate-induced neuronal toxicity. Exp Neurol 201:165-171
8. Nucci C, Tartaglione R, Cerulli A, Mancino R, Spanò A, Cavaliere F, Rombolà L, Bagetta G, Corasaniti MT, Morrone LA (2007) Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int Rev Neurobiol 82:397-406
9. Russo R, Cavaliere F, Rombolà L, Gliozzi M, Cerulli A, Nucci C, Fazzi E, Bagetta G, Corasaniti MT, Morrone LA (2008) Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection. Prog Brain Res 173:575-582
10. de Keyzer Y, Valayannopoulos V, Benoist JF, Batteux F, Lacaille F, Hubert L, Chrétien D, Chadefeaux-Vekemans B, Niaudet P, Touati G, Munnich A, de Lonlay P (2009) Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res 66(1):91-95
11. Fontella FU, Pulrolnik V, Gassen E et al. (2000) Propionic and Lmethylmalonic acids induce oxidative stress in brain of young rats. NeuroReport 11:541-544
12. Sadun AA (2009) Mitochondrial optic neuropathies. J Neurol Neurosurg Psychiatry 72:423-425
13. Haas D, Niklowitz P, Hörster F et al. (2009) Coenzyme Q10 is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria. J Inherit Metab Dis 32(4):570-575